Owing to their effectiveness in reducing body weight, once-daily subcutaneous administration of liraglutide 3.0 mg has been approved, and once-weekly subcutaneous administration of semaglutide 2.4 mg is being investigated in phase III trials, for obesity management
However, the supplementation of L-carnitine at five gram or more per day has been reported to side effects such as diarrhoea
Scenario 3: Renal Impairment Metformin is contraindicated or used with caution in patients with reduced kidney function
Taking certain medicines can interfere with how your body absorbs vitamin B12
La DL50 in caso di somministrazione per via intraperitoneale superiore a 3600 mg/kg e maggiore di 1600 mg/kg, quando la somministrazione sia per via endovenosa
To detect GLP-1 secretion from enteroendocrine cell supernatants, we exploit a reporter cell line that expresses the recombinant GLP-1 receptor in combination with the chAMPion reporter system in a CHO background